Tech Company Financing Transactions
Bioliberty Funding Round
On 11/2/2026, Bioliberty raised $3.3 million in Series A funding from 25m Health, Ballad Ventures and Tampa General Hospital.
Transaction Overview
Company Name
Announced On
11/2/2026
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to accelerate its commercial rollout within the United States market, expand clinical trial programs across its partner hospital networks, scale internal engineering and customer success teams, and advance the manufacturing setup of its therapeutic hardware.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
3rd floor, Canning Exchange, 10 Canning Street
Edinburgh, EH3 8EG
UK
Edinburgh, EH3 8EG
UK
Phone
Undisclosed
Website
Email Address
Overview
We're shaping a future where recovery from mobility-limiting conditions and injuries is more personalized, accessible, and effective; so patients can regain their independence. Today, our work focuses on upper extremity therapy, combining gamified therapy and innovative soft robotics to improve outcomes for patients and boost efficiency in the clinic. Tomorrow, we're advancing our wearable technologies, extending therapy beyond traditional settings, and leveraging AI to enable more individualized treatment.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/2/2026: Marble Cognition venture capital transaction
Next: 11/2/2026: Cent Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








